207 related articles for article (PubMed ID: 21131325)
1. Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.
Park JH; Dias CA; Lee SB; Valentini SR; Sokabe M; Fraser CS; Park MH
Protein Eng Des Sel; 2011 Mar; 24(3):301-9. PubMed ID: 21131325
[TBL] [Abstract][Full Text] [Related]
2. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
Wolff EC; Kang KR; Kim YS; Park MH
Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
[TBL] [Abstract][Full Text] [Related]
3. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
Park MH
J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
[TBL] [Abstract][Full Text] [Related]
4. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani.
Chawla B; Kumar RR; Tyagi N; Subramanian G; Srinivasan N; Park MH; Madhubala R
PLoS One; 2012; 7(3):e33138. PubMed ID: 22438895
[TBL] [Abstract][Full Text] [Related]
5. Higher activity of recombinant bovine deoxyhypusine synthase vs. human deoxyhypusine synthase.
Huang JK; Tsai S; Huang GH; Gowda PG; Walzer AM; Wen L
Protein Expr Purif; 2004 May; 35(1):32-8. PubMed ID: 15039063
[TBL] [Abstract][Full Text] [Related]
6. Functional significance of eIF5A and its hypusine modification in eukaryotes.
Park MH; Nishimura K; Zanelli CF; Valentini SR
Amino Acids; 2010 Feb; 38(2):491-500. PubMed ID: 19997760
[TBL] [Abstract][Full Text] [Related]
7. Post-translational formation of hypusine in eIF5A: implications in human neurodevelopment.
Park MH; Kar RK; Banka S; Ziegler A; Chung WK
Amino Acids; 2022 Apr; 54(4):485-499. PubMed ID: 34273022
[TBL] [Abstract][Full Text] [Related]
8. Essential role of eIF5A-1 and deoxyhypusine synthase in mouse embryonic development.
Nishimura K; Lee SB; Park JH; Park MH
Amino Acids; 2012 Feb; 42(2-3):703-10. PubMed ID: 21850436
[TBL] [Abstract][Full Text] [Related]
9. Neuron-specific ablation of eIF5A or deoxyhypusine synthase leads to impairments in growth, viability, neurodevelopment, and cognitive functions in mice.
Kar RK; Hanner AS; Starost MF; Springer D; Mastracci TL; Mirmira RG; Park MH
J Biol Chem; 2021 Nov; 297(5):101333. PubMed ID: 34688659
[TBL] [Abstract][Full Text] [Related]
10. Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction: identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A.
Kang KR; Kim YS; Wolff EC; Park MH
J Biol Chem; 2007 Mar; 282(11):8300-8. PubMed ID: 17213197
[TBL] [Abstract][Full Text] [Related]
11. Recessive Rare Variants in Deoxyhypusine Synthase, an Enzyme Involved in the Synthesis of Hypusine, Are Associated with a Neurodevelopmental Disorder.
Ganapathi M; Padgett LR; Yamada K; Devinsky O; Willaert R; Person R; Au PB; Tagoe J; McDonald M; Karlowicz D; Wolf B; Lee J; Shen Y; Okur V; Deng L; LeDuc CA; Wang J; Hanner A; Mirmira RG; Park MH; Mastracci TL; Chung WK
Am J Hum Genet; 2019 Feb; 104(2):287-298. PubMed ID: 30661771
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme.
Park JH; Aravind L; Wolff EC; Kaevel J; Kim YS; Park MH
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):51-6. PubMed ID: 16371467
[TBL] [Abstract][Full Text] [Related]
13. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
[TBL] [Abstract][Full Text] [Related]
14. Mutational analyses of human eIF5A-1--identification of amino acid residues critical for eIF5A activity and hypusine modification.
Cano VS; Jeon GA; Johansson HE; Henderson CA; Park JH; Valentini SR; Hershey JW; Park MH
FEBS J; 2008 Jan; 275(1):44-58. PubMed ID: 18067580
[TBL] [Abstract][Full Text] [Related]
15. Deoxyhypusine Modification of Eukaryotic Translation Initiation Factor 5A (eIF5A) Is Essential for Trypanosoma brucei Growth and for Expression of Polyprolyl-containing Proteins.
Nguyen S; Leija C; Kinch L; Regmi S; Li Q; Grishin NV; Phillips MA
J Biol Chem; 2015 Aug; 290(32):19987-98. PubMed ID: 26082486
[TBL] [Abstract][Full Text] [Related]
16. Biological Relevance and Therapeutic Potential of the Hypusine Modification System.
Pällmann N; Braig M; Sievert H; Preukschas M; Hermans-Borgmeyer I; Schweizer M; Nagel CH; Neumann M; Wild P; Haralambieva E; Hagel C; Bokemeyer C; Hauber J; Balabanov S
J Biol Chem; 2015 Jul; 290(30):18343-60. PubMed ID: 26037925
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning of bovine eIF5A and deoxyhypusine synthase cDNA.
Huang JK; Tsai S; Huang GH; Sershon VC; Alley AM; Wen L
DNA Seq; 2004 Feb; 15(1):26-32. PubMed ID: 15354351
[TBL] [Abstract][Full Text] [Related]
18. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.
Preukschas M; Hagel C; Schulte A; Weber K; Lamszus K; Sievert H; Pällmann N; Bokemeyer C; Hauber J; Braig M; Balabanov S
PLoS One; 2012; 7(8):e43468. PubMed ID: 22927971
[TBL] [Abstract][Full Text] [Related]
19. Assay of deoxyhypusine hydroxylase activity.
Park JH; Wolff EC; Park MH
Methods Mol Biol; 2011; 720():207-16. PubMed ID: 21318876
[TBL] [Abstract][Full Text] [Related]
20. The deoxyhypusine synthase mutant dys1-1 reveals the association of eIF5A and Asc1 with cell wall integrity.
Galvão FC; Rossi D; Silveira Wda S; Valentini SR; Zanelli CF
PLoS One; 2013; 8(4):e60140. PubMed ID: 23573236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
